Sodium Dichloroacetate and 3-Bromopyruvate induce loss of cell viability and metabolic alterations in melanoma and breast cancer cells. RevSALUS [Internet]. 6 de Abril de 2022 [citado 11 de Dezembro de 2024];4(Sup):83. Disponível em: https://revsalus.com/index.php/RevSALUS/article/view/306